The Advantage plan offers several additional protections, including a variety of alerts
State-level Medicaid coverage indicates whether an individual state includes obesity-indicated GLP-1s (Saxenda, Wegovy, and Zepbound) or Type 2 diabetes-indicated GLP-1s (Ozempic, Mounjaro, and Rybelsus) on its formulary or preferred drug list, including non-preferred or restricted coverage
In the past years, different studies had described an altered gut microbiota in T2D, finding a microbial signature for the disease and a relationship between gut microbiota and specific characteristic of T2D such as insulin resistance [54]
2018, www.medicalnewstoday.com/articles/321590
Third-party testing provides an extra layer of security
70% of patients achieved Definition of Remission in SLE or no disease activity, while 89% reached residual disease activity targets